Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Immunotherapy

Primed for a response

Nature Reviews Cancer volume 15, pages 258–259 (2015)Cite this article

Subjects

Patients who received Td also had significantly increased progression-free and overall survival

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

References

  1. Mitchell, D. A. & Batich, K. A. et al. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. Nature 519, 366–369 (2015)

    CAS  Article  Google Scholar 

Download references

Authors
  1. Sarah Seton-Rogers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Seton-Rogers, S. Primed for a response. Nat Rev Cancer 15, 258–259 (2015). https://doi.org/10.1038/nrc3945

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrc3945

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing